President Ram Nath Kovind launches pulse polio programme for 2018 on eve of National Immunisation Day
President Ram Nath Kovind launched the Pulse Polio programme for 2018 by administering polio drops to children below five years at the Rashtrapati Bhavan in New Delhi
New Delhi: President Ram Nath Kovind on Saturday launched the Pulse Polio programme for 2018 by administering polio drops to children below five years at the Rashtrapati Bhavan in New Delhi.
The president administered the drops on the eve of National Immunisation Day, which is observed tomorrow, an Union Health Ministry statement said.
Over 17 crore children below five years across the country will be given polio drops as part of the Government of India's drive, it said.
"We need to remain vigilant and maintain the population's immunity and carry out sensitive surveillance till global polio eradication happens as the poliovirus is still circulating in other parts of the world which may reinfect us," Union Health Minister JP Nadda said on the occasion.
He said that the government is making all the possible efforts to protect children from diseases.
"It is important that all vaccines under the programme reach every child of our country," Nadda said.
To mitigate the risk of poliovirus importation, immunity against the infection is maintained through national and sub-national polio rounds along with sustained high-quality surveillance, he said.
To provide additional protection to our children, the health ministry has also introduced the injectable Inactivated Polio Vaccine (IPV) into its routine immunisation programme, the minister said.
Nadda said that the Universal Immunisation Programme (UIP) is focusing on to protect children from more diseases than ever before and has introduced several new vaccines such as the Pneumococcal Conjugate vaccine, Rotavirus vaccine and the Measles-Rubella vaccine.
He said that strengthening of immunisation programmes has significantly contributed to the decline in the Infant Mortality Rate from 39 in 2014 to 34 per 1,000 live births in 2016 (as per SRS reports).
More nations support easing patent rules on COVID-19 vaccines; IP waiver not a solution, insists Big Pharma
The vaccine manufacturing industry said that reducing bottlenecks in supply chains and a scarcity of ingredients that go into vaccines are more pressing issues than waiving patents
Yogi govt orders journalists to be given priority for COVID-19 vaccine, separate centres to be allotted
The scheme, which will also cover non-accredited journalists and freelancers, was announced on a day the state reported 13,264 news cases in 24 hours
CEO Albert Bourla said that Pfizer is aware that 'access to vaccines is critical'. "Unfortunately, our vaccine is not registered in India although our application was submitted months ago," the CEO added